Glycostem Therapeutics Employee Directory
Biotechnology ResearchNorth Brabant, Netherlands11-50 Employees
Glycostem Therapeutics is a Netherlands-based biotechnology company founded in 2007 that centers its work on immunotherapy using natural killer cells. It has built a GMP-compliant NK cell production platform designed for industrial-scale manufacturing. The company is developing cancer cell therapies based on NK cells through internal programs aimed at advancing effective and safe treatments. Glycostem is located in Oss, North Brabant, and operates within the biotechnology research sector. It has pursued external collaborations to support its NK-cell program, including a 2020 partnership with LUMICKS to enhance NK cell–mediated immunotherapy, and other collaborations with Zelluna Immunotherapy and Phio Pharmaceuticals.